Man Group
LKFT icon

Man Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Man Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80,209
Closed -$2.41M – 2441
2026
Q1 		$2.41M Buy
80,209
+32,628
+69% +$1.08M ﹤0.01% 1498
2025
Q4 		$1.56M Buy
47,581
+11,384
+31% +$368K ﹤0.01% 1545
2025
Q3 		$1.25M Buy
+36,197
New +$1.16M ﹤0.01% 1588

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Madison Avenue Partners
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DME Capital Management
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Man Group's LKFT Position: Q2 2026 in Review

Man Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 80,209 shares — an estimated $2.41M sold.

Man Group first reported a position in LKFT in Q3 2025 and held it in 3 quarters. The position peaked at $2.41M in Q1 2026. 78 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Man Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 80,209 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $2.41M.
  • Man Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2025 and held it in 3 quarters.
  • Man Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.41M in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.